Biaryl Compounds as Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia (AML)
ACS Med Chem Lett
.
2022 Feb 1;13(2):158-159.
doi: 10.1021/acsmedchemlett.2c00017.
eCollection 2022 Feb 10.
Author
Ram W Sabnis
1
Affiliation
1
Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
PMID:
35178168
PMCID:
PMC8842110
DOI:
10.1021/acsmedchemlett.2c00017
No abstract available
Publication types
Editorial